AspirinPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalTiclopidineThromboxane B2Cyclooxygenase InhibitorsPlatelet AggregationSalicylatesSymptom AssessmentTreatment OutcomeDepressionPlatelet Function TestsDrug Therapy, CombinationProspective StudiesRisk FactorsQuestionnairesTime FactorsFollow-Up StudiesBlood PlateletsSeverity of Illness IndexFibrinolytic AgentsSodium SalicylateHemorrhageAnticoagulantsBehavioral SymptomsAsthma, Aspirin-InducedPsychiatric Status Rating ScalesGastrointestinal HemorrhageWarfarinTablets, Enteric-CoatedDose-Response Relationship, DrugCyclooxygenase 1Gastrointestinal DiseasesBleeding TimeIbuprofenProstaglandin-Endoperoxide SynthasesPlatelet ActivationPrevalenceThromboxanesThrombosisStrokeThromboxane A2Quality of LifeCohort StudiesMyocardial InfarctionRetrospective StudiesAffective SymptomsRecurrenceCyclooxygenase 2 InhibitorsDipyridamoleDouble-Blind MethodCross-Sectional StudiesAcetaminophenAsthmaAnxietyDrug ResistanceLipoxinsDepressive DisorderIncidenceIndomethacinLongitudinal StudiesGastric MucosaRisk AssessmentDrug Administration ScheduleStomach UlcerDrug HypersensitivityStress Disorders, Post-TraumaticSulfinpyrazoneRandomized Controlled Trials as TopicReye SyndromeCyclooxygenase 2FatigueSex FactorsNaproxenCase-Control StudiesAge FactorsPainProstaglandinsComorbidityPrimary PreventionUnited StatesChronic DiseaseSalicylic AcidLogistic Models